Benign as well as malignant neoplasms including EBV-associated lymphoproliferative disorders and skin malignancies have been reported in association with tacrolimus treatment.
Takroliimus- raviga seoses on kirjeldatud healoomulisi ja pahaloomulisi kasvajaid, sealhulgas EBV- ga seotud lümfoproliferatiivseid haigusi ja naha pahaloomulisi kasvajaid.